Drugs, Specialty Syringes
Total Trials
6
As Lead Sponsor
3
As Collaborator
Total Enrollment
714
NCT03920566
The Effect of ENZAlutamide on the Anti-Xa Levels of Patients Receiving DOACs
Phase: N/A
Role: Collaborator
Start: May 31, 2019
Completion: Apr 30, 2020
NCT05102578
Understanding Persistent Pain Using a Decision Aid Tool in a Scottish Pharmacy Setting.
Start: Jan 1, 2022
Completion: May 31, 2023
NCT05476705
Identifying Drug-related Problems at ED Triage (DRP-EDiT) V1
Start: Apr 30, 2023
Completion: Sep 30, 2023
NCT07162610
Efficacy and Safety of Rejuviel V in the Correction of Midface Volume Deficit
Role: Lead Sponsor
Start: Apr 7, 2024
Completion: Mar 30, 2026
NCT06779071
Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.
Phase: Phase 3
Start: Jan 8, 2025
Completion: Jun 30, 2026
Loading map...